ARCHIVES

Zytiga and Prednisone Extends Overall Survival in mCRPC Trial

This article is from The Cancer Letter archive.

Vol. 37 No. 10 | October 31, 2014

Download PDF Visit The Full Archive

Related Articles

Aromasin Approved By FDA For ER+ Early Breast Cancer

October 28, 2005

Steckel Object To Remarks By Korn Comparing Southern California Centers Unfavorably To NCCP Consortium

November 2, 1984

Walter Curran Succeeds Brian Leyland-Jones As Director Of Emory’s Cancer Center

September 25, 2009

HHS Agency Says It Has No Jurisdiction And No Cause to Act on I-ELCAP Allegations

March 2, 2012

ASCO To Include Chernobyl Talk, Educational sessions

May 1, 1987

NCA To Hear Centers’ Reaction, Other Subcommittee, Scientific Reports

November 11, 1977